tiprankstipranks

Gary B. Gordon Insider Profile

11 Followers
Gary B. Gordon, Director at TriSalus Life Sciences, holds 72.51K shares in TriSalus Life Sciences (Ticker: TLSI), holds 0.00 shares in Ayala Pharmaceuticals (Ticker: AYLA). Most recently, Gary B. Gordon Bought ― shares of TriSalus Life Sciences on May 18, 2026 for an estimated value of $24.60K.
tipranks
Gary B. Gordon

Gary B. Gordon
TriSalus Life Sciences (TLSI)
Director

Ranked #36,428 out of 108,699 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+39.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$350K
100.00%
A breakdown of Gary B. Gordon's holdings

Insider Roles

TriSalus Life Sciences
(TLSI)
Director
Roles that Gary B. Gordon holds in companies

Most Profitable Insider Trade

Stock:
TriSalus Life Sciences
(TLSI)
Rating:Informative Buy
Date:May 18, 2026 - Today
Return:+73.90%
The most profitable trade made by Gary B. Gordon

Gary B. Gordon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TriSalus Life Sciences
May 18, 2026
Director
Informative Buy
24.60K
$350.22K
AYLA
Ayala Pharmaceuticals
Jan 23, 2023
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Gary B. Gordon's performance on stock

Gary B. Gordon insider profile FAQ

What is the percentage of profitable transactions made by Gary B. Gordon?
The percentage of profitable transactions made by Gary B. Gordon is 100%.
    What is the average return per transaction made by Gary B. Gordon?
    The average return per transaction made by Gary B. Gordon is 39.70%.
      What stocks does Gary B. Gordon hold?
      Gary B. Gordon holds: TLSI, AYLA stocks.
        What was Gary B. Gordon’s latest transaction?
        Gary B. Gordon latest transaction was an Informative Buy of $24.60K.
          What was Gary B. Gordon's most profitable transaction?
          Gary B. Gordon’s most profitable transaction was an Informative Buy of TLSI stock on May 18, 2026. The return on the trade was 73.90%.
            What is Gary B. Gordon's role in TriSalus Life Sciences?
            Gary B. Gordon's role in TriSalus Life Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.